<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.4" extension="2015-08-01"/>
  <id root="309d01b8-6cf1-44de-879f-55cfd09b2df8"/>
  <code code="11488-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Consult note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Madam C. J. Walker</title>
  <effectiveTime value="20260223120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="199cc3f1-1f09-45f5-a487-f5e231df6ae8"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="9aa0dae9-75dd-4bed-8340-c87c769d3ff8" extension="HR-ET019-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-19-7062"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Sarah</given><family>Walker</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19761223"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260223120000-0500"/>
    <assignedAuthor><id root="d77db864-91d7-479d-8384-cc97a9929761"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Desmond</given><family>Achterberg</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260223120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="d77db864-91d7-479d-8384-cc97a9929761"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Desmond</given><family>Achterberg</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <inFulfillmentOf>
    <order><id root="f0a9ff51-aa60-4123-b51a-8e0c32fa7ee6"/></order>
  </inFulfillmentOf>
  <documentationOf>
    <serviceEvent classCode="PCPR"><effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="d77db864-91d7-479d-8384-cc97a9929761"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Desmond</given><family>Achterberg</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="3ff85e57-cb55-4461-a401-9f73ed755855"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Two-week review of the 24-hour ambulatory blood pressure and the repeat kidney tests, with a kidney ultrasound and a nephrology consultation</originalText></code>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="d77db864-91d7-479d-8384-cc97a9929761"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Desmond</given><family>Achterberg</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.1" extension="2014-06-09"/>
    <code code="42349-1" codeSystem="2.16.840.1.113883.6.1" displayName="Reason for referral (narrative)"/>
    <title>Reason for Referral</title>
    <text><paragraph>Albumin in the urine (286 mg/g) and an eGFR of 54 by the race-free CKD-EPI 2021 equation in a 49-year-old woman with high blood pressure readings awaiting ambulatory confirmation, left ventricular hypertrophy on ECG and protein on a dipstick a year ago. Please advise on the cause, any further tests, kidney-protective treatment and her blood pressure target, APOL1 testing, and a monitoring plan that fits a schedule of travel most weeks. [S]</paragraph><paragraph>Urgency: Within two weeks, on the day of her two-week visit, so that she makes one trip. [S]</paragraph><paragraph>Questions for the consultant:</paragraph><list listType="ordered"><item>Is this hypertensive kidney disease, or does she need tests for another cause, or a kidney biopsy?</item><item>Which medicines do you advise for her blood pressure and kidneys, and what is her blood pressure target?</item><item>Should she start an SGLT2 inhibitor without diabetes?</item><item>Should she be offered APOL1 genetic testing, and how would the result be used?</item><item>How should we monitor potassium, creatinine and albumin, given that she travels most weeks?</item><item>What is her risk of kidney failure, and when should she see you again?</item></list></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Madam Walker, 49, is seen at the request of Dr. Okonjo-Bell on the day of her two-week visit. She asked to be addressed as Madam Walker. Her ambulatory monitor showed a 24-hour mean of 149/94, daytime 154/98 and night 140/88, and her home readings average 152/96. Her office has sent last year&apos;s executive physical: creatinine 1.18 mg/dL and protein 1+ on a dipstick. She has had morning headaches on some days. She has no visible blood in the urine, no foamy urine she has noticed, no swelling, rash, joint pain, mouth ulcers or kidney stones, and takes no NSAIDs, supplements or herbal products. No known family kidney disease; both parents died when she was a child. She asked plainly whether she will need dialysis and said she would take whatever medicines were needed but would not give up her travel. [S]</paragraph><paragraph>Historical basis. These claims are historical evidence, not findings from a modern examination.</paragraph><list><item>Madam C. J. Walker was born Sarah Breedlove on December 23, 1867, in Delta, Louisiana, the daughter of Owen and Minerva Anderson Breedlove. Both parents had been enslaved on a Madison Parish plantation, and she was their first child born into freedom. [D]</item><item>Both her parents had died by the time she was seven, and she went to live with an older sister and moved across the river to Vicksburg, Mississippi. She married Moses McWilliams at fourteen, had her only child, Lelia (later A&apos;Lelia), and was widowed at twenty. She then moved to St. Louis, where she worked as a laundress and cook, sometimes for as little as a dollar a day. [D]</item><item>While working as a laundress she began to lose her hair, a problem many Black women of her time shared. Her biographers attribute it to scalp disease such as dandruff, poor diet, a hard life and harsh washing products, in an era when most homes lacked indoor plumbing. In 1904 she began using and selling another Black woman&apos;s hair grower as a sales agent, then developed her own sulfur-containing ointments and shampoos to treat scalp disease. [D]</item><item>In Denver she married Charles Joseph Walker, a newspaper advertising salesman (in January 1906, or 1905 in one account), and began calling herself Madam Walker, in part to avoid the familiar forms of address then used for Black women. She launched her own hair-care line there, set up headquarters and a training school for her agents in Pittsburgh in 1908, and moved the company to Indianapolis in 1910. She trained thousands of sales agents, &quot;hair culturists,&quot; who earned a share of the profits. She kept the name after the marriage ended. [D]</item><item>As her wealth grew she became a philanthropist and activist: she gave to the YWCA and paid tuition for students at Tuskegee Institute, and in 1915 she sued over discrimination at an Indianapolis theater. [D]</item><item>The physical demands she placed on herself undermined her health, and she suffered from high blood pressure. She went for a rest cure at Hot Springs, Arkansas, in 1916, but otherwise did not slow her pace. [D]</item></list><paragraph>4 later historical claims are omitted because they describe events after the index age. See the teaching note.</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="1bfae93d-11f0-44bb-af03-0c79cb4c12e9"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260209"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="72a26b8e-cf56-484d-b2df-01374dcae091"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Losartan 50 mg oral tablet, one tablet each morning</td><td>One tablet each morning, at the same home time when traveling</td><td>Oral route</td><td>2026-02-23 to 2026-03-09</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgery</td><td>One tablet each morning, with sick-day rules</td><td>Oral route</td><td>2026-02-23</td><td>active</td><td>S</td></tr><tr ID="medication-4"><td>Atorvastatin 20 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-02-23</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="7a262d70-6d2c-4943-9dd7-1a6ee6770099"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260223"/><high value="20260309"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="979492" codeSystem="2.16.840.1.113883.6.88" displayName="losartan potassium 50 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="af317579-53ed-481a-b89f-b737c6b4ad71"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I12.9" codeSystem="2.16.840.1.113883.6.90" displayName="Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e6f8a391-faef-41b0-bf03-de55c70cf277"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.31" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3a"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="d3ef980e-1a27-441e-a1b6-968c9fe2b1c8"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260223"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1545658" codeSystem="2.16.840.1.113883.6.88" displayName="empagliflozin 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="2fbf490e-bc5b-49f9-b8e6-3120d75748ff"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.31" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3a"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="84e0c56c-f3b5-49c6-982b-e3f801630612"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260223"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="617310" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 20 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ab337560-ac02-4b8e-9938-94371b64f7c0"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E78.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hyperlipidemia, unspecified"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="18646b22-a2fe-45ea-9b43-557b7eb09143"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="N18.31" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3a"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirm</td><td>resolved</td><td>confirmed</td>
    <td>R03.0</td><td>S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.</td>
  </tr>
  <tr ID="problem-2">
    <td>Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 2021 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigated</td><td>resolved</td><td>confirmed</td>
    <td>R80.9</td><td>S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.</td>
  </tr>
  <tr ID="problem-3">
    <td>Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressure</td><td>active</td><td>confirmed</td>
    <td>I12.9</td><td>S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis.</td>
  </tr>
  <tr ID="problem-4">
    <td>Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 2021 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6%</td><td>active</td><td>confirmed</td>
    <td>N18.31</td><td>S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease.</td>
  </tr>
  <tr ID="problem-5">
    <td>Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate)</td><td>active</td><td>confirmed</td>
    <td>E78.5</td><td>S — Synthetic laboratory finding.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="6c0bbc1e-d832-435f-a206-f72de8bb2435"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260209"/><high value="20260223"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="60fc317f-a388-4d22-8830-212b020d2d08"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260209"/><high value="20260223"/></effectiveTime>
          <value xsi:type="CD" code="R03.0" codeSystem="2.16.840.1.113883.6.90" displayName="Elevated blood-pressure reading, without diagnosis of hypertension"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="1018ae0a-d327-4df2-b09c-2ed30dcb7326"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260209"/><high value="20260223"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="684461bb-cc7a-4369-ac20-8fd8bb7d9917"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260209"/><high value="20260223"/></effectiveTime>
          <value xsi:type="CD" code="R80.9" codeSystem="2.16.840.1.113883.6.90" displayName="Proteinuria, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="b0663ee6-dfe6-49e8-a05e-2d589e213b3c"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260223"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="40fa38a2-46ae-4ffa-8a31-de3f62b63812"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260223"/></effectiveTime>
          <value xsi:type="CD" code="I12.9" codeSystem="2.16.840.1.113883.6.90" displayName="Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="2eedc3dc-255c-4553-b937-31bd69d203a6"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260223"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e50f681d-b22b-438a-ab6d-e341e7822279"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-4"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260223"/></effectiveTime>
          <value xsi:type="CD" code="N18.31" codeSystem="2.16.840.1.113883.6.90" displayName="Chronic kidney disease, stage 3a"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="f0eabfeb-5531-452f-8ada-f2271d4a86b5"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260209"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="c4a5bf2c-d564-483c-8b0c-ff5b6b03a054"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-5"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260209"/></effectiveTime>
          <value xsi:type="CD" code="E78.5" codeSystem="2.16.840.1.113883.6.90" displayName="Hyperlipidemia, unspecified"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-02-23; see the referring visit&apos;s Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well, articulate and engaged</td></tr><tr><td>Vital signs</td><td>Blood pressure 160/100 and pulse 80, measured by the clinic nurse today</td></tr><tr><td>Cardiovascular</td><td>Regular rhythm; sustained apex beat; no bruits</td></tr><tr><td>Extremities</td><td>No ankle swelling; no rash</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-16"><td>2026-02-23</td><td>Albumin/Creatinine [Mass Ratio] in Urine</td><td>294</td><td>mg/g</td><td>Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)</td><td>High</td><td>S</td></tr>
  <tr ID="result-17"><td>2026-02-23</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>1.21</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>High</td><td>S</td></tr>
  <tr ID="result-18"><td>2026-02-23</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>55</td><td>mL/min/{1.73_m2}</td><td>60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a</td><td>Low</td><td>S</td></tr>
  <tr ID="result-19"><td>2026-02-23</td><td>Calcium [Mass/volume] in Serum or Plasma</td><td>9.4</td><td>mg/dL</td><td>8.6-10.3 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-20"><td>2026-02-23</td><td>Phosphate [Mass/volume] in Serum or Plasma</td><td>3.6</td><td>mg/dL</td><td>2.5-4.5 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-21"><td>2026-02-23</td><td>Parathyrin.intact [Mass/volume] in Serum or Plasma</td><td>58</td><td>pg/mL</td><td>15-65 pg/mL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-22"><td>2026-02-23</td><td>25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma</td><td>31</td><td>ng/mL</td><td>30-100 ng/mL</td><td>Normal</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="bf2172a8-f4b7-4da7-a0db-70b7c53ebd97"/>
      <code code="9318-7" codeSystem="2.16.840.1.113883.6.1" displayName="Albumin/Creatinine [Mass Ratio] in Urine"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="37c89dab-abd0-4cb2-ada7-05053bac7bb2"/>
          <code code="9318-7" codeSystem="2.16.840.1.113883.6.1" displayName="Albumin/Creatinine [Mass Ratio] in Urine"/>
          <text><reference value="#result-16"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="294" unit="mg/g"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)</text>
              <value xsi:type="IVL_PQ"><high value="29" unit="mg/g"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="3cf7c542-1191-4f1d-89f3-cec22dba6ab4"/>
      <code code="51990-0" codeSystem="2.16.840.1.113883.6.1" displayName="Basic metabolic panel - Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="043990b3-6bdd-44a8-a67d-6c2403824419"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-17"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="1.21" unit="mg/dL"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="14589d0d-2a46-4061-8d5a-691b751ba374"/>
      <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="37684613-afc0-489d-8088-12bde9558e04"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-18"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="55" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="6344a8a5-63b4-436e-86f6-e7baffcd1cab"/>
      <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="190e768f-e081-4119-a50b-1a4808b1b35e"/>
          <code code="17861-6" codeSystem="2.16.840.1.113883.6.1" displayName="Calcium [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-19"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="9.4" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>8.6-10.3 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="8.6" unit="mg/dL"/><high value="10.3" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="4e30e7e7-9859-4184-9b1d-31fcea034758"/>
      <code code="2777-1" codeSystem="2.16.840.1.113883.6.1" displayName="Phosphate [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="68e4c0e7-a1bd-45fb-8459-165b725b53b4"/>
          <code code="2777-1" codeSystem="2.16.840.1.113883.6.1" displayName="Phosphate [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-20"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="3.6" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>2.5-4.5 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="2.5" unit="mg/dL"/><high value="4.5" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="48546d01-a605-434f-ae2f-4911506509ed"/>
      <code code="2731-8" codeSystem="2.16.840.1.113883.6.1" displayName="Parathyrin.intact [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="14c42f03-95a1-4b7f-b9cd-1d39b2f6bc4c"/>
          <code code="2731-8" codeSystem="2.16.840.1.113883.6.1" displayName="Parathyrin.intact [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-21"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="58" unit="pg/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>15-65 pg/mL</text>
              <value xsi:type="IVL_PQ"><low value="15" unit="pg/mL"/><high value="65" unit="pg/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="dac88189-f20f-4025-b55d-55d759c8f736"/>
      <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260223"/><high value="20260223"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="b9770b57-ba39-4fc1-947e-64a365081d3a"/>
          <code code="62292-8" codeSystem="2.16.840.1.113883.6.1" displayName="25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-22"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260223"/>
          <value xsi:type="PQ" value="31" unit="ng/mL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>30-100 ng/mL</text>
              <value xsi:type="IVL_PQ"><low value="30" unit="ng/mL"/><high value="100" unit="ng/mL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.8"/>
    <code code="51848-0" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation note"/>
    <title>Assessment</title>
    <text><list listType="ordered"><item>Chronic kidney disease G3a A2 (N18.31). Albuminuria and a reduced eGFR present for more than a year: CKD G3a A2, high risk on the KDIGO heat map. Long-standing hypertension with left ventricular hypertrophy and retinopathy, a bland sediment without hematuria, albuminuria below 300 mg/g and normal-sized kidneys make hypertensive kidney disease the most likely cause. A primary glomerular disease is less likely, and a biopsy is not needed now. Her 5-year kidney failure risk is 1.6% (4-variable KFRE): low, and treatment can lower it further. The race-free equation stages her correctly; the older equation with a race coefficient would have reported an eGFR of about 60. [S]</item><item>Hypertension with chronic kidney disease (I12.9). Stage 2 hypertension confirmed by ambulatory monitoring, with a non-dipping pattern. With albuminuria, a renin-angiotensin blocker at the maximum tolerated dose is the foundation, chosen for the kidney disease and not for her race; an ARB avoids the cough of an ACE inhibitor, which matters for her work. Target below 130/80, and a systolic near 120 if she tolerates it with standardized measurement. [S]</item></list><paragraph>Data reviewed: Dr. Okonjo-Bell&apos;s intake note and results: creatinine 1.22 mg/dL, eGFR 54 at intake and 1.21 mg/dL, eGFR 55 today (CKD-EPI 2021, race-free); potassium 4.4 mmol/L; urine albumin-to-creatinine ratio 286 mg/g at intake and 294 mg/g today; urinalysis 1+ protein without blood, bland sediment; calcium 9.4 mg/dL, phosphate 3.6 mg/dL, parathyroid hormone 58 pg/mL, 25-hydroxyvitamin D 31 ng/mL; A1c 5.4%; LDL 174 mg/dL; hemoglobin 12.4 g/dL. ECG: left ventricular hypertrophy by voltage. Kidney ultrasound this morning: right kidney 10.4 cm, left 10.6 cm, normal cortical thickness, mildly increased echogenicity, no hydronephrosis, stones or cysts. Ambulatory and home readings as above; clinic 160/100 today. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.10" extension="2014-06-09"/>
    <code code="18776-5" codeSystem="2.16.840.1.113883.6.1" displayName="Plan of care note"/>
    <title>Plan of Treatment</title>
    <text><list><item>Losartan 50 mg each morning, increased to 100 mg after two weeks if potassium is below 5.5 mmol/L and creatinine has risen by less than 30%. [S]</item><item>Empagliflozin 10 mg daily for kidney protection, indicated at her eGFR and albuminuria without diabetes; expect a small early dip in eGFR. [S]</item><item>Sick-day rules: hold losartan and empagliflozin on days of vomiting, diarrhea or not eating, and restart after a day of normal eating and drinking. [S]</item><item>Potassium and creatinine two to four weeks after each start or increase, then every six months with the urine albumin; booking the draws on her days at home is acceptable. [S]</item><item>Amlodipine as the next medicine if blood pressure stays above goal on the maximum losartan dose; no potassium-based salt substitutes. [S]</item><item>Hepatitis B, hepatitis C and HIV tests now, as part of the evaluation of new CKD, and hepatitis B vaccination if she is not immune. [S]</item><item>APOL1 genotyping may be offered with genetic counseling: two high-risk variants raise the lifetime risk of kidney disease and help explain it, but the result would not change today&apos;s treatment; it is her choice whether and when to test. [S]</item><item>No biopsy now; reconsider for hematuria, albuminuria rising above 1,000 mg/g despite treatment, or an unexplained fall in eGFR of more than 30%. [S]</item><item>Avoid NSAIDs, and tell any clinician about her kidneys before contrast dye. [S]</item><item>Discussed with Dr. Okonjo-Bell after the visit. The diagnosis, the low 5-year risk and each medicine were explained to Madam Walker with the numbers, and she agreed to start losartan and empagliflozin today. APOL1 testing was explained and written information given; she will decide later. [S]</item><item>Follow-up: Nephrology review in about six months, by video if she prefers, or sooner for potassium above 5.5 mmol/L, a fall in eGFR of more than 30%, albuminuria rising, or blood pressure not at goal on three medicines; Dr. Okonjo-Bell continues care and monitoring. [S]</item></list></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
